[Effect of nitrogen derivative of verrucarin E, VER-I, on biology and development of morphological, histochemical and histoenzymatic changes in experimental neoplasms in animals].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D008099:Liver / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008321:Mammary Glands, Animal / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010537:Peritoneum / Q000378:metabolism; D011758:Pyrroles / Q000494:pharmacology; D051381:Rats; D011915:Rats, Inbred BUF; D014255:Trichothecenes / Q000494:pharmacology / Q000627:therapeutic use
D011758:Pyrroles; D014255:Trichothecenes; C032865:VER I; C012095:verrucarin E
Badania wpływu pochodnej azotowej werukaryny E.--wer-I na biologie, rozwój zmian morfologicznych, histochemicznych i histoenzymatycznych w nowotworach doświadczalnych u zwierzat.